Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Buc & Beardsley was a premier boutique law firm based in Washington, D.C., that specialized exclusively in Food and Drug Administration (FDA) regulatory law. Founded by Nancy Buc, a former Chief Counsel of the FDA, and Kate Beardsley, the firm was widely recognized as a leading authority on the Federal Food, Drug, and Cosmetic Act. They provided strategic legal and regulatory counsel to pharmaceutical, biotechnology, and medical device companies regarding product development, clinical trials, and marketing approvals. The firm was particularly noted for its expertise in handling complex compliance issues and representing clients in administrative proceedings and litigation against the agency. Although the firm is no longer active, its founders remain influential figures in the history of life sciences and FDA legal practice. During its operation, it served as a critical advisor to both emerging biotechs and established global pharmaceutical corporations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Buc & Beardsley.